The needle market size has grown strongly in recent years. It will grow from $8.82 billion in 2025 to $9.5 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to expansion of vaccination programs, rising use of injectable therapies, growth in hospital and clinical procedures, increasing prevalence of chronic diseases, expansion of diagnostic testing services.
The needle market size is expected to see strong growth in the next few years. It will grow to $12.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising focus on healthcare worker safety, growing home-based care and self-injection adoption, increasing global diabetes prevalence, expansion of outpatient and ambulatory care services, rising demand for minimally invasive procedures. Major trends in the forecast period include growing adoption of safety needles to prevent needle-stick injuries, rising demand for disposable and single-use needles, increasing use of pen needles for diabetes management, expansion of needles in blood collection and diagnostic procedures, growing preference for sterile and pre-packaged needle solutions.
The increasing number of ambulatory surgical centers (ASCs) is set to drive the growth of the needle market in the coming years. ASCs are specialized healthcare facilities that focus on providing outpatient surgical procedures, eliminating the need for overnight hospital stays. The rise in ASCs is attributed to technological advancements, the demand for outpatient procedures, and the appeal of specialized care. Needles play a vital role in ASCs, enabling various procedures such as injections, suturing, and tissue sampling. They are essential for delivering medications, drawing blood, and ensuring precise wound closure. For instance, a report by Olympus America Inc. in July 2023 revealed that ASCs increased from 6,109 facilities last year to 6,223 in 2023, with an expected 12% growth over the next five years. Thus, the growing number of ASCs is fueling the needle market's expansion.
Key players in the needle market are concentrating on developing innovative solutions, such as cutting-edge conventional transbronchial needles, to revolutionize minimally invasive diagnostics. These needles are advanced medical instruments used in bronchoscopy procedures to obtain tissue samples from the lungs or surrounding structures. For example, Broncus Medical Inc., a US-based medical device manufacturer, introduced the BIOSTAR in September 2023 - a cutting-edge conventional transbronchial needle aspiration (cTBNA) and endobronchial ultrasound (EBUS) TBNA (EBUS-TBNA) needle. The BIOSTAR needles offer superior diagnostic accuracy, sample adequacy, and sensitivity compared to conventional methods, especially for lung cancer staging and sarcoidosis diagnosis. They are available in sizes ranging from 25G to 19G, impacting sample quantity, blood aspiration, sample quality, and diagnostic yield. BIOSTAR needles represent a significant advancement in minimally invasive diagnostic procedures, enhancing patient care and diagnostic outcomes.
In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical device manufacturer, acquired Ypsomed’s pen-needle and blood-glucose-monitoring (BGM) business. Through this acquisition, MTD increased its total pen-needle production capacity to over 2.5 billion units, strengthening its position as a leading global provider of pen needles. Ypsomed Holding AG is a Switzerland-based diabetes care technology company recognized for its portfolio of injection and monitoring solutions.
Major companies operating in the needle market are Becton Dickinson, Terumo Corporation, B. Braun AG, NIPRO Corporation, Smiths Medical, Cardinal Health, Hindustan Syringes and Medical Devices, Retractable Technologies, Owen Mumford, Ypsomed, Vygon, ICU Medical, Novo Nordisk, Medtronic, Boston Scientific, Cook Medical, Stryker, Teleflex, Nipro Medical Europe, Baxter International.
North America was the largest region in the needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the needle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the needle market by increasing costs for imported raw materials such as stainless steel, polymers, and precision manufacturing components. These effects are most visible in asia-pacific and north america, where large-scale needle manufacturing relies on global supply chains. Higher input costs have influenced pricing for safety and specialty needles across hospitals and diagnostic centers. On the positive side, tariffs have encouraged local production, domestic sourcing of materials, and investments in regional manufacturing capabilities, improving long-term supply security.
The needle market research report is one of a series of new reports that provides needle market statistics, including needle industry global market size, regional shares, competitors with a needle market share, detailed needle market segments, market trends and opportunities, and any further data you may need to thrive in the needle industry. This needle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Needles are slender, pointed instruments utilized in medical procedures for multiple purposes, including injections, blood collection, fluid aspiration, and tissue sampling. They typically consist of a hollow tube attached to a hub, which connects to a syringe or another medical device.
The primary types of needles are conventional needles and safety needles. Conventional needles refer to standard, non-safety needles used in medical procedures such as injections, blood draws, and other applications. These needles come in various materials such as stainless steel, plastic, glass, and peek, each used for specific applications such as surgical suture needles, pen needles for diabetes, blood collection needles, ophthalmic procedure needles, dental needles, insufflation needles, among others. They are utilized by various end-users such as hospitals, clinics, diagnostic centers, research institutions, home-based care, and others.
The needle market consists of sales of products including injection needles, intravenous (IV) catheters, lancets, and bone marrow biopsy needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The needle market size is expected to see strong growth in the next few years. It will grow to $12.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising focus on healthcare worker safety, growing home-based care and self-injection adoption, increasing global diabetes prevalence, expansion of outpatient and ambulatory care services, rising demand for minimally invasive procedures. Major trends in the forecast period include growing adoption of safety needles to prevent needle-stick injuries, rising demand for disposable and single-use needles, increasing use of pen needles for diabetes management, expansion of needles in blood collection and diagnostic procedures, growing preference for sterile and pre-packaged needle solutions.
The increasing number of ambulatory surgical centers (ASCs) is set to drive the growth of the needle market in the coming years. ASCs are specialized healthcare facilities that focus on providing outpatient surgical procedures, eliminating the need for overnight hospital stays. The rise in ASCs is attributed to technological advancements, the demand for outpatient procedures, and the appeal of specialized care. Needles play a vital role in ASCs, enabling various procedures such as injections, suturing, and tissue sampling. They are essential for delivering medications, drawing blood, and ensuring precise wound closure. For instance, a report by Olympus America Inc. in July 2023 revealed that ASCs increased from 6,109 facilities last year to 6,223 in 2023, with an expected 12% growth over the next five years. Thus, the growing number of ASCs is fueling the needle market's expansion.
Key players in the needle market are concentrating on developing innovative solutions, such as cutting-edge conventional transbronchial needles, to revolutionize minimally invasive diagnostics. These needles are advanced medical instruments used in bronchoscopy procedures to obtain tissue samples from the lungs or surrounding structures. For example, Broncus Medical Inc., a US-based medical device manufacturer, introduced the BIOSTAR in September 2023 - a cutting-edge conventional transbronchial needle aspiration (cTBNA) and endobronchial ultrasound (EBUS) TBNA (EBUS-TBNA) needle. The BIOSTAR needles offer superior diagnostic accuracy, sample adequacy, and sensitivity compared to conventional methods, especially for lung cancer staging and sarcoidosis diagnosis. They are available in sizes ranging from 25G to 19G, impacting sample quantity, blood aspiration, sample quality, and diagnostic yield. BIOSTAR needles represent a significant advancement in minimally invasive diagnostic procedures, enhancing patient care and diagnostic outcomes.
In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical device manufacturer, acquired Ypsomed’s pen-needle and blood-glucose-monitoring (BGM) business. Through this acquisition, MTD increased its total pen-needle production capacity to over 2.5 billion units, strengthening its position as a leading global provider of pen needles. Ypsomed Holding AG is a Switzerland-based diabetes care technology company recognized for its portfolio of injection and monitoring solutions.
Major companies operating in the needle market are Becton Dickinson, Terumo Corporation, B. Braun AG, NIPRO Corporation, Smiths Medical, Cardinal Health, Hindustan Syringes and Medical Devices, Retractable Technologies, Owen Mumford, Ypsomed, Vygon, ICU Medical, Novo Nordisk, Medtronic, Boston Scientific, Cook Medical, Stryker, Teleflex, Nipro Medical Europe, Baxter International.
North America was the largest region in the needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the needle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the needle market by increasing costs for imported raw materials such as stainless steel, polymers, and precision manufacturing components. These effects are most visible in asia-pacific and north america, where large-scale needle manufacturing relies on global supply chains. Higher input costs have influenced pricing for safety and specialty needles across hospitals and diagnostic centers. On the positive side, tariffs have encouraged local production, domestic sourcing of materials, and investments in regional manufacturing capabilities, improving long-term supply security.
The needle market research report is one of a series of new reports that provides needle market statistics, including needle industry global market size, regional shares, competitors with a needle market share, detailed needle market segments, market trends and opportunities, and any further data you may need to thrive in the needle industry. This needle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Needles are slender, pointed instruments utilized in medical procedures for multiple purposes, including injections, blood collection, fluid aspiration, and tissue sampling. They typically consist of a hollow tube attached to a hub, which connects to a syringe or another medical device.
The primary types of needles are conventional needles and safety needles. Conventional needles refer to standard, non-safety needles used in medical procedures such as injections, blood draws, and other applications. These needles come in various materials such as stainless steel, plastic, glass, and peek, each used for specific applications such as surgical suture needles, pen needles for diabetes, blood collection needles, ophthalmic procedure needles, dental needles, insufflation needles, among others. They are utilized by various end-users such as hospitals, clinics, diagnostic centers, research institutions, home-based care, and others.
The needle market consists of sales of products including injection needles, intravenous (IV) catheters, lancets, and bone marrow biopsy needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Needle Market Characteristics
3. Needle Market Supply Chain Analysis
4. Global Needle Market Trends and Strategies
5. Needle Market Analysis of End Use Industries
7. Global Needle Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Needle Total Addressable Market (TAM) Analysis for the Market
9. Needle Market Segmentation
10. Needle Market Regional and Country Analysis
11. Asia-Pacific Needle Market
12. China Needle Market
13. India Needle Market
14. Japan Needle Market
15. Australia Needle Market
16. Indonesia Needle Market
17. South Korea Needle Market
18. Taiwan Needle Market
19. South East Asia Needle Market
20. Western Europe Needle Market
21. UK Needle Market
22. Germany Needle Market
23. France Needle Market
24. Italy Needle Market
25. Spain Needle Market
26. Eastern Europe Needle Market
27. Russia Needle Market
28. North America Needle Market
29. USA Needle Market
30. Canada Needle Market
31. South America Needle Market
32. Brazil Needle Market
33. Middle East Needle Market
34. Africa Needle Market
36. Needle Market Competitive Landscape and Company Profiles
37. Needle Market Other Major and Innovative Companies
40. Needle Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Needle Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses needle market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for needle? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The needle market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Conventional Needles; Safety Needles2) By Application: Pen Needles In Diabetes; Blood Collection Needles; Ophthalmic Procedure Needles; Dentistry Needles
3) By End User: Hospital; Clinics; Diagnostic Centers; Home-Based Care
Subsegments:
1) By Conventional Needles: Hypodermic Needles; Intravenous (Iv) Needles; Insulin Needles; Blood Collection Needles2) By Safety Needles: Safety Hypodermic Needles; Safety Insulin Needles; Safety Blood Collection Needles; Auto-Disable Safety Needles
Companies Mentioned: Becton Dickinson; Terumo Corporation; B. Braun AG; NIPRO Corporation; Smiths Medical; Cardinal Health; Hindustan Syringes and Medical Devices; Retractable Technologies; Owen Mumford; Ypsomed; Vygon; ICU Medical; Novo Nordisk; Medtronic; Boston Scientific; Cook Medical; Stryker; Teleflex; Nipro Medical Europe; Baxter International
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Needle market report include:- Becton Dickinson
- Terumo Corporation
- B. Braun AG
- NIPRO Corporation
- Smiths Medical
- Cardinal Health
- Hindustan Syringes and Medical Devices
- Retractable Technologies
- Owen Mumford
- Ypsomed
- Vygon
- ICU Medical
- Novo Nordisk
- Medtronic
- Boston Scientific
- Cook Medical
- Stryker
- Teleflex
- Nipro Medical Europe
- Baxter International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.5 Billion |
| Forecasted Market Value ( USD | $ 12.27 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
